Evaluation of Ixekizumab Using Auto-Injector or Prefilled Syringe in Participants With Moderate to Severe Plaque Psoriasis
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the serum concentration of ixekizumab after
administration using either prefilled syringe or auto-injector in participants with moderate
to severe plaque psoriasis. Treatment period is followed by 40 weeks optional safety
extension.